Research Article
Endothelial Function in Children with Acute Lymphoblastic Leukemia (ALL) May Reflect the Clinical Outcome
Figure 1
(a) Study design. (b) Treatment protocol. Protocol I in detail. Study covered the period of treatment common to all risk groups. Abbreviations. Pred, prednisone 60 mg/m2/d; VCR, vincristine 1.5 mg/m2/d; DNR, daunorubicin 30 mg/m2/d; L-Asp, L-Asparaginase 5000 U/m2/d; CPM, cyclophosphamide 1000 mg/m2/d; ARA-C, cytarabine 75 mg/m2/d; 6-MP, 6-mercaptopurine 60 mg/m2/dl; MTX, methotrexate; p.o., per os; p.i., per infusion; i.t., intrathecal; d 1, day 1; d 33, day 33; SR, standard risk; IR, intermediate risk; HR, high risk.
| (a) |
| (b) |